Dutch medical equipment supplier Pie Medical Imaging has introduced its new CAAS Qardia 2.0 echocardiography software platform.

Providing ease of access, the new software measures important clinical parameters using artificial intelligence (AI) driven workflows.

It can be deployed as an in-hospital zero-footprint solution, which means it can be accessed from any PC in the hospital network through a web browser.

With the latest version, comprehensive and flexible off-cart echocardiography analysis is within reach, said the company.

CAAS Qardia enables viewing and analysis that includes myocardial strain analysis of left and right ventricles, stress-echo, diastology, and proximal isovelocity surface area (PISA) valve analysis.

It automatically creates a report containing all the clinically relevant parameters that can be shared between colleagues.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Pie Medical Imaging managing director Rene Guillaume said “With CAAS Qardia 2.0 Pie Medical Imaging underscores its commitment to simplify the cardiologist’s daily practice with accurate and easy-to-use analysis tools.”

According to the company, foreshortening of views of the heart can negatively affect functional measurements, such as the frequently unnoticed phenomenon of myocardial strain.

The new technology aims to counteract this by providing the user with quality control indices.

It is currently available in a server-based or classical stand-alone setup and has received approval from the US Food and Drug Administration (FDA) as well as CE mark.

Pie Medical Imaging stated that healthcare institutions can use the new platform for all their multi-vendor echocardiography image sets.

The company is focused on cardiovascular image analysis and visualisation. It hosts global sales for the CAAS and 3mensio product lines.

Together with 3mensio Medical Imaging, Pie Medical Imaging is a part of the Esaote Group, which offers biomedical equipment that includes dedicated magnetic resonance imaging (MRI), Medical IT and ultrasound devices.